Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Clearpoint Neuro Inc

CLPT ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Small Cap Analyst: BUY

Last Close

$15.34

▼ -0.52%

Market Cap $467.93M · Vol 106.16K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$467.93M

Small Cap

Div Yield

N/A

EPS Growth

-47.04%

YoY

RSI (14)

55.42

Momentum

Beta

1.26

vs Market

52W High

$30.01

48.88% below

52W Low

$8.31

84.60% above

Volume

106.16K

Avg 193.39K

P/B

14.34

Price-to-book

ROE

N/A

Return on equity

Free Float

94.34%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Clearpoint Neuro Inc (CLPT) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CLPT pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+7.95%

-3.88%

+20.13%

+13.21%

YTD

+12.13%

+31.34%

+155.67%

-13.33%

Financials & Valuation

TTM · Annual

Total Revenue	$36.97M
Net Income	$-25,540,000.00
Revenue Growth (YoY)	+18.07%
Gross Margin	61.38%
Operating Margin	-65.36%
Net Profit Margin	-69.08%
ROE	N/A
ROA · ROIC	-37.22% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	10.48
P/B	14.34
P/FCF	N/A
EPS Growth	-47.04%
Outstanding Shares	30.50M

Technical Indicators

50-Day SMA	$15.58
200-Day SMA	$13.68
RSI (14)	55.42
Beta	1.26
52-Week High	$30.01
52-Week Low	$8.31

Volume Today	106.16K
Avg Daily Volume (30D)	193.39K
Relative Volume	0.55x
Volatility (10D)	98.03
Volatility (30D)	67.35
Free Float	94.34%

Analyst Consensus

BUY

Current Price $15.34

Mean Target $25.67

52W Low$8.31 52W High$30.01

Current

Target

$8.31 $30.01

Current Analyst target

+67.32% upside potential · 3 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001T6D542

ISINUS18507C1036

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateNov 4, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.